Kinetics and Predictors of Hepatitis B Surface Antigen (HBsAg) Loss After Commencing Hepatitis B Virus (HBV)–Active Antiretroviral Therapy in the Setting of HIV and Chronic HBV Coinfection

Journal:

Clinical Infectious Diseases

Published:

2025-05-31

DOI:

10.1093/cid/ciaf281

Affiliations:

11

Authors:

16

Go to article

Institutions	Authors	Share
Victorian Infectious Diseases Reference Laboratory (VIDRL), Doherty Institute, Australia	5.500000	0.34
Chulalongkorn University (CU), Thailand	3.000000	0.19
The Peter Doherty Institute for Infection and Immunity (Doherty Institute), Australia	2.500000	0.16
University of Malaya (UM), Malaysia	2.000000	0.13
VHS – Infectious Diseases Medical Centre, India	1.000000	0.06
Monash University, Australia	0.500000	0.03
Alfred Hospital, Australia	0.500000	0.03
Burnet Institute, Australia	0.333333	0.02
The University of Adelaide (Adelaide Uni), Australia	0.333333	0.02
Karolinska Institute (KI), Sweden	0.333333	0.02

Interested in Medical Microbiology?